Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M

Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets

HONG KONG SAR - EQS Newswire - 27 March 2024 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2023 (the "Year").